News

Together, HemCon and ProMetic will develop and validate a sterile, single-use antibody capture device for the removal of isoagglutinin antibodies. The exclusive agreement covers the development of a

According to the Translational Genomics Research Institute (TGen), Safeway’s donation represents a 37% increase from the $500,000 that the company gave TGen last year. The contributions both years

With ClearTrial Portfolio Planning, available in the enterprise edition of ClearTrial version 2.7, clinical development organizations can now roll up protocol-level study plans into portfolio-level forecasts, providing instant

The technology utilizes a gas ionization process producing a stable thin focused beam of ionized gas that can be controlled in a range of temperatures and intensities, providing

The union between the two CROs will significantly improve Tigermed’s clinical data management serviceability and broaden MacroStat’s business line, said Tigermed. Ye Xiaoping, CEO and founder of Tigermed,

The collaboration agreement focuses on the operation of the facility, as well as the management of samples deposited by Duke University, and its clients and collaborators, including samples

In this multi-center, randomized, open-label Phase II study, clinical effect of a combination of carboplatin, etoposide and obatoclax will be compared to the standard chemotherapeutic therapy of carboplatin

The agreement provides Advanced Oncology Systems (AOS) with the rights to sell in most eastern European countries, with a primary focus in Hungary, Poland, Romania, Bulgaria, the Russian

Enobia is investigating enzyme replacement therapy (ERT) with ENB-0040 for the treatment of this rare and often crippling genetic bone disorder for which there is no approved treatment.